CLINICAL_TRIALS
trial_result
· 2012-08-14
Clinical Trial Update: Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma [Phase 2]
Summary
Phase 2 trial evaluating adjuvants accompanying peptide immunization in high-risk melanoma completed; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: High-Risk Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2012-08-14